Internal Medicine, Gastroenterology · Delray Beach, FL
NPI
1538130828
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4675 Linton Blvd, Suite 202
Delray Beach, FL, 33445
Phone (561) 495-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$708K
26,784 services
Medicare patients, 2024
1,360
Average age 78
Drug cost, 2024
$1.6M
4,035 prescriptions
Company payments, 2025
$2,993
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James Chong was code J3380 (injection, vedolizumab, intravenous, 1 mg), 17,100 times for 39 patients. In total James Chong billed 26,784 services in 60 codes, and Medicare paid $708K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 17,100 | 39 | $17.38 | $297K |
| 99214 Office E&M - Established | Office | 862 | 568 | $96.19 | $83K |
| 43239 Upper GI Endoscopy | Facility | 383 | 372 | $71.21 | $27K |
| 99213 Office E&M - Established | Office | 331 | 279 | $64.37 | $21K |
| 45385 Colonoscopy - Lesion Removal | Facility | 325 | 322 | $213.39 | $69K |
| 45380 Lower GI Endoscopy - Other | Facility | 220 | 218 | $73.88 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 139 | 79 | $62.82 | $8,732 |
| 99204 Office E&M - New | Office | 133 | 133 | $115.15 | $15K |
| 99203 Office E&M - New | Office | 88 | 88 | $68.61 | $6,038 |
| 99223 Hospital E&M - Initial | Facility | 77 | 77 | $138.86 | $11K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 69 | 69 | $186.50 | $13K |
| 96365 Intravenous Infusion, Hydration | Office | 62 | 44 | $49.47 | $3,067 |
| 99233 Hospital E&M - Subsequent | Facility | 42 | 26 | $94.98 | $3,989 |
| 76981 Ultrasound - Nonspecific | Office | 39 | 39 | $78.07 | $3,045 |
| 36415 Venipuncture Blood Collection | Office | 38 | 36 | $8.65 | $329 |
By year: 2022 $486K for 14,493 services; 2023 $537K for 14,395 services; 2024 $708K for 26,784 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 36 | $8.65 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug James Chong prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,200 prescriptions and refills. In total James Chong wrote 4,035 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,200 | 3,128 | 376 | $20K |
| Omeprazole Generic | 471 | 1,250 | 151 | $5,288 |
| Famotidine Generic | 431 | 1,151 | 148 | $6,852 |
| Colestipol Hcl Generic | 178 | 408 | 70 | $19K |
| Dicyclomine Hcl Generic | 154 | 278 | 71 | $3,135 |
| Lactulose Generic | 152 | 214 | 85 | $2,719 |
| Sucralfate Generic | 142 | 273 | 62 | $7,008 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 94 | 94 | 94 | $15K |
| Linzess Linaclotide | 89 | 153 | 24 | $80K |
| Esomeprazole Magnesium Generic | 72 | 184 | 23 | $2,540 |
| Mesalamine Generic | 64 | 162 | 18 | $35K |
| Hydrocortisone Generic | 63 | 67 | 31 | $938 |
| Dexlansoprazole Dr Dexlansoprazole | 49 | 132 | 12 | $21K |
| Amitriptyline Hcl Generic | 45 | 127 | 14 | $500 |
| Metronidazole Generic | 42 | 42 | 34 | $253 |
Brand drugs: - claims; generic drugs: 3,432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Chong $2,993 ($2,993 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $1,124.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 41 | $1,124 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $332 |
| Janssen Biotech, Inc. JNJ | 12 | $265 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $170 |
| Lilly USA, LLC LLY | 11 | $130 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $130 |
| Madrigal Pharmaceuticals MDGL | 4 | $121 |
| Ardelyx, Inc. ARDX | 5 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $105 |
| Gilead Sciences, Inc. GILD | 3 | $76.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.